Wang, H., Yao, Z., Tang, H., Zhao, Y., Zhang, X., Yao, S., . . . Liu, Y. (2016). Weekly nanoparticle albumin-bound paclitaxel in combination with cisplatin versus weekly solvent-based paclitaxel plus cisplatin as first-line therapy in Chinese patients with advanced esophageal squamous cell carcinoma. Onco Targets Ther.

Wang, Hai-ying, Zhi-hua Yao, Hong Tang, Yan Zhao, Xiao-san Zhang, Shu-na Yao, Shu-jun Yang, ja Yan-yan Liu. "Weekly Nanoparticle Albumin-bound Paclitaxel in Combination With Cisplatin Versus Weekly Solvent-based Paclitaxel Plus Cisplatin As First-line Therapy in Chinese Patients With Advanced Esophageal Squamous Cell Carcinoma." Onco Targets Ther 2016.

Wang, Hai-ying, et al. "Weekly Nanoparticle Albumin-bound Paclitaxel in Combination With Cisplatin Versus Weekly Solvent-based Paclitaxel Plus Cisplatin As First-line Therapy in Chinese Patients With Advanced Esophageal Squamous Cell Carcinoma." Onco Targets Ther 2016.